RE: Mologic5 May 2020 19:40
From the document that has been tweeted by Mologic :
"In the UK, the target sensitivity and specificity from the MHRA was published on the 8th
April 2020, several days after ELISAs and RDTs were reported to fail evaluations as
tests for ‘immunity passports’ and seroprevalence studies.25 The required accuracy for
such tests is currently specified at >98% sensitivity and specificity (update 24th April
202026). However, all manufacturers reported lower accuracy levels than this threshold
from their own evaluations, and therefore would not have expected to pass these
stringent criteria. ".
Not sure if that is a negative ?